What is Lenvatinib?
Lenvatinib is a targeted therapy that helps treat certain cancers, including thyroid, liver, and kidney cancers. It works by blocking receptor tyrosine kinases that promote tumor growth and blood vessel formation. If you are prescribed Lenvatinib, you are taking a medication designed to slow cancer progression by interfering with signals that encourage tumor development.
What are the Uses of Lenvatinib?
Lenvatinib is primarily used to treat certain types of cancer. If you have thyroid cancer that isn’t responsive to radioiodine therapy, it helps by slowing down tumor growth. For liver cancer, particularly unresectable hepatocellular carcinoma, Lenvatinib works by blocking the blood vessels that tumors need to grow. It is also used for advanced kidney cancer, often in combination with other treatments, to help prevent cancer cell spread. for a couple of seconds
Lenvatinib is used to treat various cancers by targeting the growth and spread of tumors. If you have thyroid cancer that no longer responds to radioiodine treatment, Lenvatinib may help slow tumor growth. It is also prescribed for liver cancer that cannot be removed by surgery. In some cases, Lenvatinib is combined with other treatments to manage advanced kidney cancer, aiming to control disease progression effectively.
How Does Lenvatinib Work?
Lenvatinib works by blocking specific proteins that promote the growth and spread of cancer cells. It targets tyrosine kinases, which are involved in forming blood vessels that tumors need to grow. By inhibiting these pathways, Lenvatinib slows down tumor progression and limits its ability to spread to other parts of the body. If you’re taking Lenvatinib, it helps disrupt the signals that support cancer cell growth, allowing your body to better control the disease. for 6 seconds
Lenvatinib works by blocking specific proteins known as receptor tyrosine kinases. These proteins help tumors grow and develop new blood vessels. If you take Lenvatinib, it interferes with these signals, slowing down the tumor’s growth and spread. This targeted action allows the medication to work against cancer cells while reducing the impact on healthy tissue.
What are the Side Effects of Lenvatinib?
Lenvatinib may cause various side effects. If you are taking this medication, you might experience high blood pressure, fatigue, diarrhea, decreased appetite, or weight loss. You may also notice nausea, mouth sores, or changes in taste. In some cases, abdominal pain or swelling can occur. Although rare, serious side effects such as liver problems or heart issues might develop. Always inform your doctor if you experience any new or worsening symptoms.
How long is the Lenvatinib treatment?
The duration of Lenvatinib treatment varies depending on the type of cancer being treated and how well the patient responds to the medication.
In clinical trials, the median treatment duration for Lenvatinib ranged from 6 to 16 months for different types of cancer. However, some patients may continue treatment for longer periods if they are benefiting from it and not experiencing severe side effects.
It is important to note that the decision of how long to continue Lenvatinib treatment should be made by the patient’s doctor based on their individual circumstances. The doctor will monitor the patient’s response to the medication and adjust the treatment plan as needed.
What are the tablets available for the Lenvatinib in Pakistan?
In Pakistan, the brand name for Lenvatinib is Lenvima, manufactured by Eisai. It is available in capsule form in various strengths.
Please note that this information is not exhaustive and may not reflect all available brands or formulations of Lenvatinib in Pakistan. It is crucial to consult with a healthcare professional or pharmacist to get the most accurate and up-to-date information on available medications.
